Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 8,490.00
-100.00 (-1.16%)
At close: Apr 2, 2026
Jeil Pharma Holdings Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 14,635 | -51,159 | -16,250 | -74,556 | -3,482 |
Depreciation & Amortization | 14,949 | 14,099 | 12,556 | 10,905 | 8,983 |
Loss (Gain) From Sale of Assets | -12.08 | -7.97 | -0.53 | -23.98 | -1,930 |
Asset Writedown & Restructuring Costs | - | 45,204 | 28,604 | 78,335 | 16,388 |
Loss (Gain) From Sale of Investments | -5,175 | -5,586 | -2,916 | -6,271 | -20,857 |
Loss (Gain) on Equity Investments | -24,722 | -9,855 | -9,329 | -5,708 | -8,452 |
Stock-Based Compensation | 696.53 | 1,026 | 578.03 | 472.48 | 163.17 |
Provision & Write-off of Bad Debts | 558.49 | -682.67 | -2,423 | -308.41 | 1,669 |
Other Operating Activities | 28,900 | 26,151 | 13,309 | 2,014 | 6,516 |
Change in Accounts Receivable | 26,816 | -11,223 | -14,328 | -12,722 | 10,835 |
Change in Inventory | 4,868 | -3,266 | -12,170 | 1,347 | 9,341 |
Change in Accounts Payable | -50,188 | -7,721 | -9,849 | 3,358 | 10,024 |
Change in Other Net Operating Assets | -10,936 | 7,563 | 7,803 | -14,098 | -15,795 |
Operating Cash Flow | 390.26 | 4,542 | -4,416 | -17,256 | 13,403 |
Operating Cash Flow Growth | -91.41% | - | - | - | - |
Capital Expenditures | -8,283 | -4,340 | -6,223 | -15,462 | -23,688 |
Sale of Property, Plant & Equipment | 12.2 | 8.35 | 87.64 | 23.98 | 37,800 |
Sale (Purchase) of Intangibles | -1,045 | -2,523 | -3,571 | -5,948 | 91.43 |
Investment in Securities | -5,312 | 8,508 | -3,770 | 169.41 | -10,506 |
Other Investing Activities | -0 | 620.43 | 51.01 | 106.46 | 3,627 |
Investing Cash Flow | -14,628 | 2,274 | -13,425 | -21,110 | 7,325 |
Short-Term Debt Issued | 24,115 | 13,843 | 25,834 | 27,163 | - |
Long-Term Debt Issued | 5,000 | - | - | - | 12,288 |
Total Debt Issued | 29,115 | 13,843 | 25,834 | 27,163 | 12,288 |
Short-Term Debt Repaid | -16,500 | -13,000 | - | - | -42,477 |
Long-Term Debt Repaid | -938 | -5,254 | -4,084 | -6,377 | -7,146 |
Total Debt Repaid | -17,438 | -18,254 | -4,084 | -6,377 | -49,623 |
Net Debt Issued (Repaid) | 11,677 | -4,411 | 21,750 | 20,785 | -37,335 |
Issuance of Common Stock | - | - | - | - | 7,498 |
Repurchase of Common Stock | - | - | - | -396.98 | -810.02 |
Dividends Paid | -183.17 | -1,134 | -1,134 | -1,475 | -1,590 |
Other Financing Activities | -280.72 | 19,762 | -0 | 26,001 | 20,000 |
Financing Cash Flow | 11,213 | 14,217 | 20,616 | 44,914 | -12,238 |
Foreign Exchange Rate Adjustments | -607.38 | 1,749 | -496.29 | -369.37 | -93.19 |
Net Cash Flow | -3,631 | 22,782 | 2,279 | 6,179 | 8,397 |
Free Cash Flow | -7,893 | 202.38 | -10,638 | -32,717 | -10,284 |
Free Cash Flow Margin | -1.20% | 0.03% | -1.32% | -4.13% | -1.35% |
Free Cash Flow Per Share | -513.98 | 13.19 | -692.99 | -2131.27 | -669.95 |
Cash Interest Paid | 7,593 | 8,051 | 9,044 | 4,891 | 2,592 |
Cash Income Tax Paid | 9,093 | 3,289 | 2,092 | -596.65 | 5,401 |
Levered Free Cash Flow | 2,341 | 11,675 | -19,889 | -20,230 | 7,866 |
Unlevered Free Cash Flow | 7,025 | 17,221 | -13,219 | -16,510 | 9,921 |
Change in Working Capital | -29,439 | -14,647 | -28,544 | -22,115 | 14,405 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.